GSK Says Dreamm-3 Phase 3 Study For Blenrep Didn’t Meet Primary Endpoint
admin By Michael Susin GSK PLC said Monday that its Dreamm-3 Phase 3 study in patients…
Read Moreendpoint
GSK respiratory syncytial virus vaccine Phase 3 trial meets primary endpoint
GSK PLC said Thursday that a Phase 3 trial of its respiratory syncytial virus vaccine…
Read More